Target intelligence / Profile preview

Ribosomal protein L12 pseudogene 12 (RPL12P12)

Target
RPL12P12
Molecular classification
Pseudogene, Ribosomal protein pseudogene, Other
01

Overview

RPL12P12 is a processed **pseudogene** derived from the ribosomal protein L12 gene (RPL12). Pseudogenes are non-functional genomic segments that resemble known genes but cannot produce functional protein, often due to disabling mutations or lack of necessary regulatory elements. The RPL12P12 locus does not encode a functional protein and is one of many ribosomal protein pseudogenes dispersed throughout the human genome, thought to arise from retrotransposition events[5][2][6]. While the parent gene RPL12 is involved in assembly of the 60S ribosomal subunit and catalysis of protein synthesis[1][3], its pseudogenes do not contribute directly to these activities. There is currently no evidence that RPL12P12 acts as a biomarker, drug target, or has significant disease relevance. If you are seeking information on a therapeutic target or receptor, this entry does **not** meet those criteria. The proper functional protein would be “60S ribosomal protein L12” (RPL12), not RPL12P12[1][3].

Other names
dJ999L4.1RPL12L3RPL12_16_1689ribosomal protein L12-like 3ribosomal protein S12 pseudogene 12 (possible error/confusion)RPL12P12
02

Mechanism of action

None

03

Biological functions

None; as a pseudogene, it does *not* encode functional protein or participate directly in ribosomal/protein synthesis[5][2].
04

Disease associations

None; pseudogenes do not have direct disease associations, though some ribosomal protein pseudogenes have been studied for potential indirect regulatory roles. No evidence for RPL12P12 involvement in disease[5].
05

Safety considerations

None
06

Interacting drugs

None
07

Biomarkers

None

Beyond the preview

Go deeper on Ribosomal protein L12 pseudogene 12 (RPL12P12).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L12 pseudogene 12 (RPL12P12).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call